SCHEMBL17523266

SCHEMBL17523266

Cc1cc(OCc2ccccc2)c2c(c1)O[C@H](c1ccc(OCc3ccccc3)c(OCc3ccccc3)c1)[C@H](OC(=O)NC(C)C)C2

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ STING1 Q86WV6 1/20 0.45
▸ MEN1 O00255 1/20 0.42
▸ MAPT P10636 1/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ ALDH1A1 P00352 2/20 0.42
▸ CYP3A4 P08684 1/20 0.42
▸ MAPK1 P28482 1/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ HPGD P15428 1/20 0.39
▸ HTT P42858 1/20 0.39
▸ CETP P11597 1/20 0.38
▸ ABCB1 P08183 5/20 0.38
▸ GABRA1 P14867 2/20 0.38
▸ GABRB2 P47870 2/20 0.38
▸ APP P05067 2/20 0.37
▸ HSP90AB1 P08238 1/20 0.36
▸ CASP1 P29466 1/20 0.36
▸ CASP3 P42574 1/20 0.36
▸ CASP7 P55210 1/20 0.36
▸ CASP6 P55212 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20169881 0.92 STING1 (0.50) STING1MEN1MAPTKMT2AALDH1A1
SCHEMBL16016991 0.88 ALDH1A1 (0.55) STING1MEN1MAPTKMT2AALDH1A1
SCHEMBL15450265 0.83 STING1 (0.43) STING1MEN1MAPTKMT2AALDH1A1
SCHEMBL15450261 0.83 STING1 (0.43) STING1MEN1MAPTKMT2AALDH1A1
SCHEMBL17358236 0.83 STING1 (0.42) STING1MEN1MAPTKMT2AALDH1A1
SCHEMBL17358246 0.83 STING1 (0.42) STING1MEN1MAPTKMT2AALDH1A1
SCHEMBL16016989 0.83 PDE4A (0.42) STING1MEN1MAPTKMT2AALDH1A1
SCHEMBL17358245 0.83 STING1 (0.42) STING1MEN1MAPTKMT2AALDH1A1
SCHEMBL16017082 0.82 STING1 (0.42) STING1MEN1MAPTKMT2AALDH1A1
SCHEMBL16017066 0.82 XDH (0.46) STING1MEN1MAPTKMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9975869-B2 Analogues of epicatechin and related polyphenols SPHAERA PHARMA PVT. LTD. (IN) 2018-05-22 — — US disclosed
US-20160039781-A1 NOVEL ANALOGUES OF EPICATECHIN AND RELATED POLYPHENOLS SPHAERA PHARMA PVT. LTD. (SG) 2016-02-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160039781-A1 NOVEL ANALOGUES OF EPICATECHIN AND RELATED POLYPHENOLS PGC, TEAD3, TEAD4 STING1 4635/4885MEN1 4171/4885MAPT 1857/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback